Evidence map›Paper›PMID 35056018›Full record

ArticlePathogens (Basel, Switzerland)2022

Regulatory Effect of Irresistin-16 on Competitive Dual-Species Biofilms Composed of

Xiangyu Hu, Min Wang, Yan Shen, Lingjun Zhang, Yihuai Pan, Yan Sun, Keke Zhang

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Zoliflodacin inhibitsFrontiers in cellular and infection microbiology · 2025
    Article
  6. Article
  7. Article
  8. [Developments in Research on the Relationship BetweenSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2023
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xiangyu HuInstitute of Stomatology, School of Stomatology, Wenzhou Medical University, Wenzhou 325035, China.
Min WangInstitute of Stomatology, School of Stomatology, Wenzhou Medical University, Wenzhou 325035, China.
Yan ShenInstitute of Stomatology, School of Stomatology, Wenzhou Medical University, Wenzhou 325035, China.
Lingjun ZhangInstitute of Stomatology, School of Stomatology, Wenzhou Medical University, Wenzhou 325035, China.
Yihuai PanInstitute of Stomatology, School of Stomatology, Wenzhou Medical University, Wenzhou 325035, China.
Yan SunInstitute of Stomatology, School of Stomatology, Wenzhou Medical University, Wenzhou 325035, China.
Keke ZhangInstitute of Stomatology, School of Stomatology, Wenzhou Medical University, Wenzhou 325035, China.
Wenzhou Medical University · CN

Funding

National Natural Science Foundation of China 82001041National Natural Science Foundation of China 82170950Wenzhou Technology Bureau Project Y20210781Zhejiang Provincial Natural Science Foundation LGF19H140004Zhejiang Provincial Natural Science Foundation LGF20H140001
6 · The paper itself

Abstract

Based on the ecological plaque hypothesis, suppressing opportunistic pathogens within biofilms, rather than killing microbes indiscriminately, could be a biofilm control strategy for managing dental caries. The present study aimed to evaluate the effects of irresistin-16 (IRS-16) on competitive dual-species biofilms, which consisted of the conditional cariogenic agent

Indexed as

cariogenic virulencedual-species biofilmsirresistin-16regulatory effectStreptococcus mutansStreptococcus sanguinis

Identifiers

PMID35056018
PMCPMC8779588
OpenAlexW4205120747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.